Behaviour of indexes of platelet activity and active fibrinolysis in plasma from patients with seasonal allergic rhinitis and concomitant asthma during pollen season

Advances in Clinical and Experimental Medicine

Volumn 15, Issue 1, 2006, Pages 23-28

  Kasperska Zajac, Alicja ^a,b   Rogala, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Clinical Department of Internal Diseases Allergology and Clinical Immunology   (Poland)

Author keywords

Allergic rhinitis; Asthma; Fibrinolysis; Platelet activation; Pollen allergy

Indexed keywords

D DIMER; THROMBOCYTE FACTOR 4;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; FIBRINOLYSIS; GRASS; HAY FEVER; HUMAN; IN VIVO STUDY; MALE; MEDICAL RECORD; POLLEN ALLERGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RYE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION;

SECALE CEREALE;

EID: 33645275740     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. εR2) of eosinophils, platelets and macrophages. J Exp Med 1986, 164, 72-89.
2. Joseph M, Gounni AS, Kusnierz JP, Vorng H, Sarfati M, Kinet JP, Tonnel AB, Capron A, Capron M: Expression and function of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur J Immunol 1997, 27, 2212-2218.
3. Hasegawa S, Pawankar R, Suzuki K, Nakahata T, Furukawa S, Okumura K, Ra C: Functional expression of the high affinity receptor for IgE (FcεRI) in human platelets and its intracellular expression in human megakaryocytes. Blood 1999, 93, 2543-2551.
4. Chihara J, Fukada K, Tasuba H, Kishigari N, Sugihara R, Kubo H, Nakajima S: Platelet factor 4 enhances eosinophil IgG and IgE receptors and has eosinophil chemotactic activity. Am Rev Respir Dis 1988, 137, A421.
5. Deuel TF, Senior RM, Chang D, Griffin GL, Heinrikson RL: Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 1981, 78, 4854-4857.
6. Kaplan KL, Owen J: Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981, 57, 199-202.
7. Gallagher JS, Bernstein IL, Maccia CA, Splansky GL, Glueck HI: Cyclic platelet dysfunction in IgE-mediated allergy. J Allergy Clin Immunol 1978, 62, 229-235.
8. Szczeklik A, Milner PC, Birch J, Watkins J, Martin JF: Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb Haemost 1986, 56, 283-287.
9. Banach-Wawrzeńzyk E, Dziedziczko A, Rość D: Fibrinolysis system in patients with bronchial asthma. Med Sci Monit 2000, 6, 103-107.
10. Knauer KA, Lichtenstein LM, Adkinson NF, Fish JE: Platelet activation during antigen-induced airway reactions in asthmatic subjects. N England J Med 1981, 304, 1404-1407.
11. Averill FJ, Hubbard WC, Proud D, Gleich GJ, Lin MC: Platelet activation in the lung after antigen challenge in a model of allergic asthma. Am Rev Respir Dis 1992, 145, 571-576.
12. Sullivan PJ, Jafar ZH, Harbinson PL, Restrick LJ, Costello JF: Platelet dynamics following allergen challenge in allergic asthmatics. Respiration 2000, 67, 514-517.
13. Beasley R, Roche WR, Roberts JA, Holgate ST: Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989, 139, 806-817.
14. Grossman J: One airway one disease. Chest 1996, 111, 11-16.
15. Yamamoto H, Nagata M, Tabe K, Kimura I, Kiuchi H, Sakamoto Y, Yamamoto K, Dohi Y: The evidence of platelet activation in bronchial asthma. J Allergy Clin Immunol 1993, 91, 79-87.
16. Morrison JFJ, Pearson SB, Dean HG, Craig IR, Bramley PN: Platelet activation in nocturnal asthma. Thorax 1991, 46, 197-200.
17. Kasperska-Zajac A, Rogala B: Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure. Inflamm Res 2003, 52, 477-479.
18. Kasperska-Zajac A, Nowakowski M, Rogala B: Plasma levels of beta-thromboglobulin - an indicator of in vivo platelet activation measured in patients with pollen-induced intermittent allergic rhinitis during the pollen season and out of season. Adv Clin Exp Med 2005, 14, 59-62.
19. Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention. National Heart, Lung and Blood Institute and National Institutes of Health. Publication 2000, 02-3569.
20. Kasperska-Zajac A, Nowakowski M, Rogala B: Enhanced in vivo platelet activation in patients with atopic eczema/dermatitis syndrome. Inflammation 2005, 2004, 28, 299-302.
21. Yasuba H, Chihara J, Kino T, Satake N, Oshima S: Increased releaseability of platelet products and reduced heparin-induced platelet factor 4 from endothelial cells in bronchial asthma. J Lipid Mediat 1991, 4, 5-21.
22. Maccia CA, Gallagher JS, Ataman G, Glueck HI, Brooks SM, Bernstein IL: Platelet thrombopathy in asthmatic patients with elevated immunoglobulin E. J Allergy Clin Immunol 1977, 59, 101-108.
23. Moritani C, Ishioka S, Haruta Y, Kambe M, Yamakido M: Activation of platelets in bronchial asthma. Chest 1998, 113, 452-458.
24. Toytard A, Guenard H, Vuillemin L, Bouvot JL, Vergeret J, Ducassou D, Piquet Y, Freour P: Platelet kinetics in stable atopic asthmatic patients. Am Rev Respir Dis 1986, 134, 983-985.
25. Szczeklik A, Nizankowski R, Mruk J: Myocardial infarction in status asthmaticus. Lancet 1977, 1, 658-659.